ACE inhibitors: cough, potassium, kidneys and monitoring
ACE inhibitors are used for conditions including high blood pressure, heart failure and selected kidney disease. They can protect the heart or kidneys in the right setting, yet the same biological pathway can change kidney filtration and potassium or cause a persistent dry cough. Monitoring is part of treatment, not evidence that the medicine is inherently harmful.
Key takeaways
- Kidney function and potassium are normally checked before and after starting or changing an ACE inhibitor; a result must be interpreted against the baseline, timing, illness and other medicines.
- A dry, persistent cough is a recognised class effect, while swelling of the face, lips or tongue or difficulty breathing can indicate angioedema and needs emergency assessment.
- Pregnancy, dehydration, NSAID use, potassium supplements or salt substitutes, and accidental ACE-inhibitor-plus-ARB use can materially change safety.
What does an ACE inhibitor do?
Angiotensin-converting enzyme inhibitors reduce formation of angiotensin II, a signal that narrows blood vessels and promotes sodium retention. The result can lower blood pressure and reduce strain on the heart. In chronic kidney disease with albumin in the urine, the pathway can also reduce pressure within the kidney’s filtering units.
Examples in this catalogue include ramipril, lisinopril, enalapril and perindopril. They share a class mechanism, but ingredient, strength, indication and dosing plan are not interchangeable.
Singapore’s ACE chronic-kidney-disease guideline identifies an ACE inhibitor or ARB as a main treatment option for people with CKD and albuminuria when clinically appropriate. The hypertension guideline also includes ACE inhibitors among common first-line classes. These are indication-specific decisions, not reasons to borrow another person’s tablet.
Why are kidney function and potassium checked?
The renin-angiotensin system helps regulate blood flow through the kidneys and potassium handling. Blocking it can produce a predictable early change in creatinine or estimated glomerular filtration rate (eGFR), especially after initiation or a dose change. The meaning depends on how large the change is, when it occurred and whether dehydration, infection, low blood pressure, renal-artery disease or interacting medicines are present.
ACE’s CKD guidance recommends monitoring eGFR, creatinine and potassium, for example within two to four weeks or as clinically required, with closer monitoring when acute-kidney-injury risk is higher. It provides thresholds and follow-up actions for clinicians; those numbers should not be used as a self-directed stop/start rule.
| Monitoring item | What the clinical team is checking |
|---|---|
| Blood pressure and symptoms | Whether the intended effect is accompanied by faintness or low pressure |
| Creatinine and eGFR | How kidney filtration has changed from the person’s baseline |
| Potassium | Whether potassium has risen outside the safe range |
| Fluid status and other medicines | Whether illness, dehydration, diuretics, NSAIDs or supplements explain added risk |
The blood-pressure medicine comparison shows why this laboratory pattern differs from amlodipine or a thiazide-type diuretic.
Why can an ACE inhibitor cause a dry cough?
ACE also breaks down bradykinin and related peptides. Their accumulation is thought to contribute to a typically dry, persistent cough. It may begin soon after treatment or appear after the medicine has been used for some time. A cough is not automatically caused by the tablet: asthma, reflux, infection, smoking and heart or lung disease can look similar.
The US National Library of Medicine’s ACE-inhibitor patient guide advises reporting a new dry cough and not reducing the dose without speaking to the prescriber. A clinician may assess other causes and decide whether the benefit still outweighs the symptom or whether an alternative class is appropriate.
Do not treat the cough with repeated combination cold products without checking their active ingredients. Some contain decongestants or duplicate other medicines, while suppressing the symptom does not answer whether the ACE inhibitor is involved.
When is swelling more urgent than cough?
Angioedema is uncommon but potentially life-threatening. Swelling of the lips, tongue, face or throat, hoarseness, trouble swallowing or difficulty breathing needs emergency assessment. Call 995 in Singapore for breathing difficulty or rapidly progressing swelling. Do not wait for an ordinary clinic appointment or test whether an antihistamine is enough.
Tell every prescriber about any previous ACE-inhibitor angioedema. It is different from ankle swelling, which is more commonly associated with some calcium-channel blockers, and from a mild isolated cough. Precise symptom description matters when a combination tablet contains more than one ingredient.
Which medicines and everyday products affect the risk?
NSAID painkillers can reduce kidney blood flow, especially during dehydration or when a diuretic is also present. Potassium tablets and potassium-containing salt substitutes can compound potassium elevation. Diuretics, other blood-pressure medicines and acute illness can contribute to low pressure or kidney stress. Include over-the-counter medicines, traditional remedies and supplements in the review.
An ACE inhibitor and an angiotensin-receptor blocker (ARB) act on the same system at different points. Singapore ACE advises avoiding their routine combination in hypertension because it increases hyperkalaemia, acute kidney injury and low blood-pressure risk. A brand-name combination or an old packet can conceal this duplication, so check generic names.
If vomiting, diarrhoea, fever or poor fluid intake occurs, follow the individual’s written sick-day or clinic instructions. A general web page cannot decide whether the medicine should be held because the answer depends on the illness, kidney function, indication and other treatment.
Why does pregnancy require an early medicine review?
ACE inhibitors can harm a developing fetus and are not used during pregnancy. Pregnancy planning should therefore include a medication review before conception where possible. If pregnancy occurs or may have occurred while taking an ACE inhibitor, contact the prescriber promptly for a safe replacement plan; do not improvise a gap or use another person’s medicine.
The same review should cover breastfeeding, contraception plans and all other cardiovascular medicines. MedlinePlus advises people who are pregnant or planning pregnancy to contact their healthcare professional about ACE-inhibitor treatment.
What changes the answer?
- The reason for treatment. Hypertension, heart failure and albuminuric CKD have different expected benefits and follow-up priorities.
- The baseline and trend. One creatinine or potassium result cannot be interpreted without previous results and timing.
- Acute illness or dehydration. Vomiting, diarrhoea, fever and poor intake can rapidly change kidney perfusion.
- Other medicines. NSAIDs, diuretics, potassium products, ARBs and mineralocorticoid-receptor antagonists can alter risk.
- Pregnancy or pregnancy planning. This requires prompt prescriber-led replacement rather than routine continuation.
- Cough or swelling pattern. A stable dry cough and rapidly progressing tongue swelling are not the same urgency.
What should you bring to a monitoring review?
Bring the actual packets or an updated ingredient-and-strength list, recent blood-test results, home blood-pressure readings if requested, and the dates of any illness or new symptoms. Ask when the next kidney-function and potassium tests are due and who will review the results.
Seek prompt assessment for fainting, markedly reduced urine, severe weakness, palpitations or worsening illness. Use emergency care for facial, tongue or throat swelling, trouble breathing, chest pain or collapse.
Sources
- Singapore Agency for Care Effectiveness: Chronic kidney disease—delaying progression and reducing cardiovascular complications.
- Singapore Agency for Care Effectiveness: Hypertension—tailoring the management plan to optimise blood pressure control.
- US National Library of Medicine, MedlinePlus: ACE inhibitors.
